메뉴 건너뛰기




Volumn 62, Issue 6, 2000, Pages 681-685

Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218

Author keywords

[No Author keywords available]

Indexed keywords

CHIKUNGUNYA FEVER VACCINE; LIVE VACCINE; NEUTRALIZING ANTIBODY; PLACEBO; TSI GSD 218; UNCLASSIFIED DRUG; VIRUS VACCINE;

EID: 0034457916     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2000.62.681     Document Type: Article
Times cited : (273)

References (30)
  • 17
    • 0005489740 scopus 로고
    • Cross-Neutralization studies with group A arthropod-borne viruses
    • (1961) Bull WHO , vol.24 , pp. 735-741
    • Porterfield, J.S.1
  • 28
    • 0005404488 scopus 로고
    • An epidemic of fever in Madras-1964: A clinical study of 4,223 cases at the infectious diseases hospital
    • (1965) Ind J Med Res , vol.53 , pp. 745-753
    • Rao, A.R.1
  • 29
    • 0014099678 scopus 로고
    • Virological investigations of arbovirus infections in Ceylon, with special reference to the recent chikungunya fever epidemic
    • (1967) Ceylon Med J , vol.12 , pp. 81-92
    • Hermon, Y.E.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.